Market Tracker

09/22 5:16pm ET

Mesoblast Ltd (NASDAQ:MESO)

5.47
Delayed Data
As of Sep 22
 +0.01 / +0.18%
Today’s Change
4.01
Today|||52-Week Range
12.50
+2.24%
Year-to-Date
No recent news for Mesoblast Ltd.

Today’s Trading

Previous close5.46
Today’s open5.40
Day’s range5.37 - 5.51
Volume5,302
Average volume (3 months)27,853
Market cap$503.9M
Dividend yield--
Data as of 4:00pm ET, 09/22/2017

Growth & Valuation

Earnings growth (last year)-1,605.50%
Earnings growth (this year)+11.88%
Earnings growth (next 5 years)+24.00%
Revenue growth (last year)-95.31%
P/E ratio--
Price/Sales326.56
Price/Book0.91

Competitors

 Today’s
change
Today’s
% change
IVCInvacare Corp+0.31+1.97%
RTIXRTI Surgical Inc-0.05-1.08%
SIENSientra Inc+0.03+0.20%
OFIXOrthofix Internation...+0.09+0.19%
Data as of 4:02pm ET, 09/22/2017

Financials

Next reporting dateDecember 20, 2017
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$1.9M
Annual profit (last year)-$76.8M
Net profit margin-3,951.39%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, MD &
Executive Director
Silviu Itescu
Chief Financial Officer
Paul Hodgkinson
Corporate headquarters
Melbourne, Victoria (vic)

Forecasts